Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

Okairos to commence novel RSV vaccine Phase I clinical trial

Okairos today announced the initiation of a Phase I clinical trial evaluating a vaccine against respiratory syncytial virus (RSV), a leading cause of hospital admissions in infants and children.

25 Feb 2013

Race and possibly genetics play a role in children's sensitivity to developing allergies

Research conducted at Henry Ford Hospital shows that race and possibly genetics play a role in children's sensitivity to developing allergies.

24 Feb 2013

New data from Boehringer Ingelheim's tiotropium Respimat Phase III UniTinA-asthma programme

Tiotropium delivered once daily via Respimat significantly improved lung function and reduced asthma exacerbations in patients who remain symptomatic despite treatment with at least ICS/LABA, irrespective of their allergic status.

24 Feb 2013

Washington University creates new type of air-cleaning technology

Washington University engineering researchers have created a new type of air-cleaning technology that could better protect human lungs from allergens, airborne viruses and ultrafine particles in the air.

23 Feb 2013

FDA approves Lupin Pharmaceuticals' SUPRAX for Oral Suspension

Pharma major, Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. (collectively, Lupin) has received approval for SUPRAX (Cefixime) for Oral Suspension, 500 mg/5mL from the United States Food and Drugs Administration (FDA).

23 Feb 2013

Research into why young adults overuse short-acting bronchodilators

The high cost of medication, stigmatisation and poor acceptance of their condition are causing young adults to take a dangerous approach to managing their asthma, according to new research published today in the journal BMJ Open.

22 Feb 2013

National Jewish Health expert describes potential hazards of energy efficient homes

In an effort to protect the environment and save on energy costs, we are in the midst of a "green" home boom in this country. While that may bode well from an energy-efficiency standpoint, the trend certainly doesn't have everyone breathing easier.

22 Feb 2013

Immune Pharmaceuticals commences Phase II study with bertilimumab to treat ulcerative colitis

Immune Pharmaceuticals Ltd., a privately held Israeli company, and EpiCept Corporation announced today that Immune is initiating, following authorization from Israeli health authorities, a Phase II double-blind placebo controlled study with its lead drug, bertilimumab, in patients with moderate-to-severe ulcerative colitis.

21 Feb 2013

Asthma patients have large number of fungi in their lungs

Hundreds of tiny fungal particles found in the lungs of asthma sufferers could offer new clues in the development of new treatments, according to a team of Cardiff University scientists.

20 Feb 2013

Reduced lung function during infancy may increase risk of wheezing in young adulthood

A study in Australia suggests that reduced lung function in infancy was associated with wheezing beyond childhood at 18 years of age, according to a report published Online First by JAMA Pediatrics, a JAMA Network publication.

19 Feb 2013

Severe childhood asthma blood test hopes dashed

Blood eosinophil counts do not reliably reflect airway eosinophil concentrations in children with severe, therapy-resistant asthma, and therefore cannot be used to make therapeutic decisions, researchers report.

19 Feb 2013

Age not a major factor in asthma allergic sensitization rates

Results from a US study suggest that there is no significant difference in allergic sensitization rates between younger and older patients with asthma.

18 Feb 2013

Sleep disorder linked to reduced life quality in asthma patients

Quality of life is significantly decreased in adult patients with asthma who are at high risk for obstructive sleep apnea, results from a Korean study show.

15 Feb 2013

Cyclist pollution exposure minimized by use of quieter roads

Research suggests that using quieter streets with less traffic exposes city cyclists to lower levels of air pollution than using more congested routes, although wind-speed has a significant influence on levels of pollution exposure experienced each day.

14 Feb 2013

Regeneron fourth quarter total revenues increase to $415 million

Regeneron Pharmaceuticals, Inc. today announced financial and operating results for the fourth quarter and full year 2012 and provided an update on development programs.

14 Feb 2013

Less than 1 in 4 young people with ASD receive transition services

Health care transition (HCT) services help young people with special health care needs such as asthma or diabetes move from pediatric to adult health care. However, youths with autism spectrum disorder (ASD) have less access to these services, which are designed to prevent gaps in care and insurance coverage.

13 Feb 2013

State roundup: Calif. doc supply strains under health law

The compelling facts and figures he provided the Senate Finance Committee gave feuding Democrats and Republicans the confidence to unite behind an expedited but cautious roadmap toward a federally prescribed expansion of Medicaid in Virginia.

12 Feb 2013

LASAG trial for severe influenza initiated

...

12 Feb 2013

Diastolic hypotension key predictor of admission in pediatric asthma

Results from a large study show that diastolic hypotension is a consistent predictor of admission to hospital in all children with asthma.

12 Feb 2013

Florida Hospital, Sanford-Burnham and Takeda renew research agreement

Sanford-Burnham Medical Research Institute (Sanford-Burnham) and Florida Hospital announced today that they have renewed a research agreement with Takeda Pharmaceutical Company Limited (Takeda) to extend their collaboration to discover and evaluate new therapeutic approaches to obesity. The collaboration uses a research and drug-development model that creates an early feedback loop in the discovery pipeline.

12 Feb 2013